Lucid to Acquire Select Facilities and Assets Previously Belonging to Nikola Corporation, Will Extend Offers to 300+ Former Nikola Employees
NEWARK, Calif., April 11, 2025 /PRNewswire/ — Lucid Group, Inc. (Nasdaq: LCID), maker of the world’s most advanced electric vehicles, today announced... Read more.
Global First Engineered Exosome with INCI Name — ImmVira Leads a New Era in International Cosmetic Ingredients
SUZHOU, China, April 10, 2025 /PRNewswire/ — EonveLab, a subsidiary of ImmVira Group (“ImmVira,” or the “Company”), recently announced... Read more.
ROLLER Celebrated on AFR’s Best Places to Work List and Certified as a Great Place to Work
ROLLER’s purpose is to help create experiences that bring joy and happiness to the world. They achieve this by connecting attraction venues with powerful,... Read more.
CCV Capital’s Founding Managing Partner Wei Zhou Attends the 2025 Harvard College China Forum
CAMBRIDGE, Mass., April 10, 2025 /PRNewswire/ — From April 4th to April 6th, 2025 (Eastern Time), the 28th Harvard College China Forum was successfully held... Read more.
Plume to Introduce Access to Tokenized Gold via Matrixdock, Matrixport’s RWA Platform
NEW YORK, April 10, 2025 /PRNewswire/ — Plume, the first fully integrated blockchain and ecosystem built specifically for Real World Asset Finance (RWAfi),... Read more.
Cboe Expands Derivatives Market Intelligence Franchise into Asia Pacific with Strategic New Hire
Wei Liao to spearhead launch of Cboe’s market intelligence and content franchise in APAC Expansion reflects growing demand for derivatives trading, data, and... Read more.
Jacksonville Medical Care and Cabot Medical Care Notify Individuals of Data Security Incident
JACKSONVILLE, Ark., April 10, 2025 /PRNewswire/ — Jacksonville Medical Care (“JMC”) and Cabot Medical Care (“CMC”) are providing notice... Read more.
Halozyme Announces FDA Approval of argenx’s VYVGART® Hytrulo Prefilled Syringe Co-Formulated with ENHANZE® for Self-Injection for Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy
SAN DIEGO, April 10, 2025 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that argenx has received U.S. Food and Drug... Read more.
Oncolytics Biotech® Funds Pelareorep’s Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital
SAN DIEGO and CALGARY, AB, April 10, 2025 /PRNewswire/ — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing... Read more.
Alabama Ophthalmology Associates Provides Notice Following Data Security Incident
BIRMINGHAM, Ala., April 10, 2025 /PRNewswire/ — Alabama Ophthalmology Associates (“AOA”) experienced a data security incident that involved personal... Read more.